Anders Kristoffersson, Ph.D.

Senior Consultant

Bio

  • Joined Pharmetheus in 2018, actively working in client projects
  • Expertise includes model informed drug development, pharmacometrics, and trial design for pharmacokinetic and pharmacokinetic-pharmacodynamic modelling
  • Previously worked as Postdoctoral Researcher at Uppsala University, Sweden, where he prepared mechanism based pharmacokinetic-pharmacodynamic models for selection of antibiotic dosing regimens supported by a grant from Hoffman-La Roche
  • M.Sc. in Molecular Biotechnology Engineering (2010) and Ph.D. in Pharmaceutical Biosciences (2015) from Uppsala University, Sweden
LinkedInGoogle Scholar

Pharmetheus affiliated publications

A joint ketamine and esketamine exposure-response model of MADRS score in major depressive disorder to enable informed trial design for candidate drugs with similar mode of actionBounded integer model-based analysis of psoriasis area and severity index in patients with moderate-to-severe plaque psoriasis receiving BI 730357 treatmentBounded integer model-based analysis of psoriasis area and severity index in patients with moderate-to-severe plaque psoriasis receiving BI 730357Assessment of Expected Drug Exposure Relative Maximum Safety Limits in Early Phase Studies